Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Sorafenib Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel purification method for Sorafenib key intermediate. High yield, oxalic acid salt process. Reliable supply chain partner for pharmaceutical manufacturing.
Patent CN102675197A details a high-yield, eco-friendly route for Sorafenib intermediate. Reduces solvent use and improves purity for scalable manufacturing.
Patent CN101052619A details an improved industrial process for preparing 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide tosylate, offering significant supply chain and cost advantages.
Patent CN110885298B details a green synthesis route for Sorafenib intermediates, offering high purity and reduced waste for reliable pharmaceutical supply chains.